Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Cabaletta’s CAR-T wipes out B cells with no preconditioning
Treatment with rese-cel depleted B cells in three patients with an autoimmune disease, sparking a complete B cell reset in two of them.
Darren Incorvaia
Oct 10, 2025 11:11am
BMS inks $1.5B deal to pull Orbital into its sphere of influence
Oct 10, 2025 8:45am
3 scientists win Nobel Prize for discovery of regulatory T cells
Oct 6, 2025 7:03am
Barinthus enters reverse merger with metabolic disease biotech
Sep 30, 2025 10:39am
Rome nears end of road with planned layoffs, strategic review
Sep 23, 2025 2:00pm
Roivant reports phase 3 autoimmune win for ex-Pfizer asset
Sep 17, 2025 7:00am
